Tech Company Financing Transactions
Celleration Funding Round
SightLine Partners, Aavin Equity Advisors and Baird Capital joined a $8 million Series E capital raise for Celleration. The financing closed on 1/12/2011.
Transaction Overview
Company Name
Announced On
1/12/2011
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series E
Investors
Proceeds Purpose
This round of financing positions Celleration well for the next phase of growth and market development and provides funding to develop additional applications for MIST Therapy.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6321 Bury Dr. 15
Eden Prairie, MN 55346
USA
Eden Prairie, MN 55346
USA
Phone
Website
Email Address
Overview
The patented MIST Therapy System from Celleration is an innovative, painless ultrasound noncontact wound healing device.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Wagner
Chief Financial Officer
Christopher Geyen
VP - Manufacturing
Terri Grant
VP - R & D
Douglas Duchon
Browse more venture capital transactions:
Prev: 1/12/2011: Avinger venture capital transaction
Next: 1/12/2011: Zend Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs